Expression of genes encoding for drug metabolising cytochrome P450 enzymes and P-glycoprotein in the rat small intestine; comparison to the liver

  • Monica Lindell
  • Matti Lang
  • Hans Lennernäs


The level of expression of genes encoding for nine major xenobiotic metabolising Cytochrome P450s (CYPs) and the P-glycoprotein (Pgp) was determined in three different regions of the small intestine of male and female Sprague Dawley rats and the expression was compared with that in the liver. A semi-quantitative RT-PCR method, using the total RNA from the tissues, was established for the determination of the level of gene expression.

Four of the CYP genes: the CYP2B1, CYP2C6, CYP2C11 and CYP2D1 and the Pgp were expressed at as high levels in the small intestine as in the liver. The expression of the other CYP genes was remarkably different in the two organs. The CYP1A2, CYP2A3, CYP2E1 and CYP3A1 showed a strong expression in the liver but only a comparatively weak or no expression in the small intestine. The CYP1A1 on the other hand exhibited a stronger expression in the small intestine than in the liver.

With the exception of the CYP2A3, none of the genes showed a clear regional distribution in their small intestinal expression. Furthermore, no obvious sex difference in the expression of the CYP and Pgp genes could be observed.

Our results indicate that several of the enzymes, central for drug metabolism are differently expressed in the liver and in the small intestine of the rat which should be taken into account when using rat as a model for the bioavailability and organ specific toxicity studies of orally administered xenobiotics. The apparently strong small intestinal expression of the CYP2C genes suggests that these enzymes could play a key role in the intestinal drug metabolism in rats and therefore affect the bioavailability of those orally used drugs which are substrates of the CYP2Cs. This possibility should be investigated in more detail both in rats and humans.


Cytochrome P450 Pgp rat small intestine mRNA 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Porter T.D. and Coon M.J. (1991): Cytochrome P-450. J. Biol. Chem., 266, 13469–13472PubMedGoogle Scholar
  2. 2.
    Borst P., Schinkel A.H., Smit J.J.M., Wagenaar E., van Deemter L., Smith A.J., Eijdems E.W.H.M., Baas F. and Zaman G.J.R., (1993) Classical and Novel Forms of Multidrug Resistance and the Physiological Functions of P-glycoproteins in Mammals. Pharmac. Ther., 60, 289–299)CrossRefGoogle Scholar
  3. 3.
    Salphati L. and Benet L.Z., (1998): Modulation of P-glycoprotein Expression by Cytochrome P450 3A Inducers in Male and Female Rat Liver. Biochem. Pharmacol., 55, 387–395CrossRefPubMedGoogle Scholar
  4. 4.
    Wacher V.J., Silverman J.A., Zhang Y., Benet L.Z., (1998): Role of P-glycoprotein and Cytochrome P450 3A in Limiting Oral Absorption of Peptides and Peptidomimetics J. Pharm. Sci., 87, 1322–1330CrossRefPubMedGoogle Scholar
  5. 5.
    Nelson D.R., Kamataki T., Wexman D.J., Guengerich F.P., Estabrook R.W., Feyereisen R., Gonzalez F.J., Coon M.J., Gunsalus I.C., Gotoh O., Okuda K., and Nebert D.W., (1993): The P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers, Early Trivial Names of Enzymes, and Nomenclature. DNA and Cell Biol., 12, 1–51CrossRefGoogle Scholar
  6. 6.
    Paine M.F., Shen D.D., Kunze K.L., Perkins J.D., Marsh C.L., McVicar J.P., Barr D.M., Gillies B.S. and Thummel K.E., (1996): First-pass Metabolism of Midazolam by the Human Intestine. Clin. Pharmacol. There., 60, 14–24CrossRefGoogle Scholar
  7. 7.
    Wu C-Y., Benet L.Z., Hebert M.F., Gupta S.K., Rowland M., Gomez D.Y. and Wacher V.J., (1995): Differentiation of Absorption and Firstpass Gut and Hepatic Metabolism in Humans: Studies with Cyclosporine. Clin. Pharmacol. Ther., 58, 492–497CrossRefPubMedGoogle Scholar
  8. 8.
    Reg_rdh C.G., Edgar B., Olsson R., Kendall M., Collste P and Shansky C., (1989): Pharmacokinetics of Felodipine in Patients with Liver Disease. Eur. J. Clin. Pharmacol., 36, 473–479CrossRefGoogle Scholar
  9. 9.
    Fromm M.F., Busse D., Kroemer H.K., and Eichelbaum M. (1996): Differential Induction of Prehepatic and Hepatic Metabolism of Verapamil by Rifampin. Hepatology. 24, 796–801CrossRefPubMedGoogle Scholar
  10. 10.
    Bai J.P.F. (1994): Distribution of Brush-Border Membrane Peptidases Along the Rat Intestine. Pharmaceutical Research, 11, 897–900CrossRefPubMedGoogle Scholar
  11. 11.
    Traber P.G., McDonnell W.M., Wang W. and Florence R. (1992): Expression and Regulation of Cytochrome P-450I Genes (CYP1A1 and CYP1A2) in the Rat Alimentary Tract. Biochimicia et Biophysica Acta., 1171, 167–175Google Scholar
  12. 12.
    Zhang Q-Y., Wikoff J., Dunbar D. and Kaminsky L. (1996): Characterization of Rat Small Intestinal Cytochrome P450 Composition and Inducibility. Drug Metab. Dispos., 24, 322–328PubMedGoogle Scholar
  13. 13.
    De Waziers I., Cugnenc P.H., Yang C.S., Leroux J-P., and Beaune P.H. (1990): Cytochrome P 450 Isoenzymes, Epoxide Hydrolase and Glutathione Transferases in Rat and Human Hepatic and Extrahepatic. Tissues J. Pharmacol. Exp. Ther., 253, 387–394Google Scholar
  14. 14.
    Kaminsky L.S. and Fasco M.J. (1991): Small Intestinal Cytochromes P450. Crit. Rev. Toxicol., 21, 407–422CrossRefPubMedGoogle Scholar
  15. 15.
    Zhang J. and Ding X. (1998): Identification and Characterization of a Novel Tissue-specific Transcriptional Activating Element in the 5_-Flanking Region of the CYP2A3 Gene Predominantly Expressed in Rat Olfactory Mucosa. J. Biol. Chem., 273, 23454–23462CrossRefPubMedGoogle Scholar
  16. 16.
    Gonzalez F.J. (1989): The Molecular Biology of Cytochrome P450s. Pharmacological Reviews, 40, 243–288Google Scholar
  17. 17.
    Honkakoski P., Mäenpää J., Leikola J., Pasanen M., Juvonen R., Lang M.A. Melkonen O., and Raunio H. (1993): Cytochrome P4502A-Mediated Counmarin 7-Hydroxylation and Testosterone Hydroxylation in Mouse and Rat Lung. Pharmacol. & Toxicol., 72, 107–112CrossRefGoogle Scholar
  18. 18.
    Béréziat J-C., Raffalli F., Schmezer P., Frei E., Geneste O. and Lang M.A. (1995): Cytochrome P450 2A of Nasal Epithelium: Regulation and Role in Carcinogen Metabolism. Mol. Carcinogenesis, 14, 130–139CrossRefGoogle Scholar
  19. 19.
    Godoy W., Albano R.M., Moraes E.G., Alves Pinho P.R., Nunes R.A., Saito E.H., Higa C., Filho I.M., Pinto Kruel C.D., Schirmer C.C., Gurski R., Lang M.A., and Ribeiro Pinto L.F. (2002): CYP2A6/2A7 and CYP2E1 Expression in Human Oesophageal Mucosa: Regional anf Inter-individual Variation in Expression and Relevance to Nitrosamine Metabolism. Carcinogenesis, 23, 611–616.CrossRefPubMedGoogle Scholar
  20. 20.
    Iber H., Chen Q., Sewer M., and Morgan E.T. (1997): Regulation of Hepatic Cytochrome P450 2C11 by Glucocorticoids. Arch. Biochem. Biophys., 345, 305–310CrossRefPubMedGoogle Scholar
  21. 21.
    Hiroi T., Imaoka S., Chow T. and Funae Y. (1998): Tissue Distribution of CYP2D1, 2D2, 2D3 and 2D4 mRNA in Rats Detected by RT-PCR. Biochimica et Biophysica Acta, 1380, 305–312PubMedGoogle Scholar
  22. 22.
    Hakkak R., Korourian S., Ronis M.J.J., Ingelman-Sundberg M. and Badger T.M. (1996): Effects of Diet and Ethanol on the Expression and Localization of Cytochromes P450 2E1 and P450 2C7 in the Colon of Male Rats. Biochem. Pharmacol., 51, 61–69CrossRefPubMedGoogle Scholar
  23. 23.
    Shimizu M., Lasker J.M., Tsutsumi M. and Lieber C.S. (1990): Immunohistochemical Localization of Ethanol-Inducible P450IIE1 in the Rat Alimentary Tract. Gastroenterology, 99, 1044–1053PubMedGoogle Scholar
  24. 24.
    Kocarek T.A., Zangar R.C. and Novak R.F. (2000): Post-transcriptional Regulation of Rat CYP2E1 Expression: Role of CYP2E1 mRNA Untranslated Regions in Control of Translational Efficiency and Message Stability. Arch. Biochem. Biophys., 376, 180–190CrossRefPubMedGoogle Scholar
  25. 25.
    Kolars J.C., Schmiedlin-Ren P., Dobbins III W.O., Schuetz J., Wrighton S.A., and Watkins, P.B. (1992): Heterogeneity of Cytochrome P450IIIA Expression in Rat Gut Epithelia. Gastroenterology, 102, 1186–1198PubMedGoogle Scholar
  26. 26.
    Johnson T.N., Tanner M.S., and Tucker G.T., (2000): A Comparison of the Ontogeny of Enterocytic and Hepatic Cytochromes P450 3A in the Rat. Biochem. Pharmacol., 60, 1601–1610.CrossRefPubMedGoogle Scholar
  27. 27.
    Makhey V.D., Guo A., Norris D.A., Hu P., Yan J. and Sinko P.J. (1998) Characterization of the Regional Intestinal Kinetics of Drug Efflux in Rat and Human Intestine and in Caco-2 Cells. Pharmaceutical Research, 15, 1160–1167CrossRefPubMedGoogle Scholar
  28. 28.
    Mugford C.A., and Kedderis G.L. (1998): Sex-dependent Metabolism of Xenobiotics. Drug. Metabolism Reviews 30, 441–498CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Monica Lindell
    • 1
    • 2
  • Matti Lang
    • 1
  • Hans Lennernäs
    • 2
  1. 1.Department of Pharmaceutical BiosciencesUppsala UniversitySweden
  2. 2.Department of PharmacyUppsala UniversitySweden

Personalised recommendations